| Product Code: ETC9405304 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Hereditary Angioedema Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Hereditary Angioedema Market - Industry Life Cycle |
3.4 South Korea Hereditary Angioedema Market - Porter's Five Forces |
3.5 South Korea Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 South Korea Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 South Korea Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 South Korea Hereditary Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about hereditary angioedema (HAE) among healthcare professionals and patients |
4.2.2 Technological advancements in diagnosis and treatment options for HAE in South Korea |
4.2.3 Growing research and development activities focusing on HAE therapies |
4.3 Market Restraints |
4.3.1 Limited availability and accessibility of specialized HAE treatment centers in South Korea |
4.3.2 High treatment costs associated with HAE therapies |
4.3.3 Lack of comprehensive insurance coverage for HAE treatments in South Korea |
5 South Korea Hereditary Angioedema Market Trends |
6 South Korea Hereditary Angioedema Market, By Types |
6.1 South Korea Hereditary Angioedema Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 South Korea Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 South Korea Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F |
6.1.4 South Korea Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.1.5 South Korea Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F |
6.1.6 South Korea Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.2 South Korea Hereditary Angioedema Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 South Korea Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.3 South Korea Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F |
6.2.4 South Korea Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F |
6.3 South Korea Hereditary Angioedema Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 South Korea Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 South Korea Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 South Korea Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Hereditary Angioedema Market Import-Export Trade Statistics |
7.1 South Korea Hereditary Angioedema Market Export to Major Countries |
7.2 South Korea Hereditary Angioedema Market Imports from Major Countries |
8 South Korea Hereditary Angioedema Market Key Performance Indicators |
8.1 Average time to diagnosis of HAE patients in South Korea |
8.2 Number of HAE-specific treatment centers established in South Korea |
8.3 Patient adherence rates to prescribed HAE treatment regimens |
9 South Korea Hereditary Angioedema Market - Opportunity Assessment |
9.1 South Korea Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 South Korea Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 South Korea Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 South Korea Hereditary Angioedema Market - Competitive Landscape |
10.1 South Korea Hereditary Angioedema Market Revenue Share, By Companies, 2024 |
10.2 South Korea Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here